Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 3 (2006), Issue 1 (January)

1. Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma.
   Br J Haematol, 132(4): 503-11. [Abstract] [Full-text]
2. APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial.
   Pediatr Blood Cancer, 46(3): 320-4. [Abstract] [Full-text]
3. Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma.
   Pediatr Blood Cancer, 46(3): 314-9. [Abstract] [Full-text]
4. Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts.
   J Pathol, 208(3): 423-30. [Abstract] [Full-text]
5. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
   J Pathol, 208(3): 431-8. [Abstract] [Full-text]
6. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma.
   Cancer Res, 66(2): 1114-22. [Abstract] [Full-text]
7. Quality of life in long-term Hodgkin's disease survivors with chronic fatigue.
   Eur J Cancer, 42(3): 327-33. [Abstract] [Full-text]
8. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
   J Clin Oncol, 24(4): 605-11. [Abstract] [Full-text]

© 2004-2012 Hodgkin's Disease Research Today. All Rights Reserved.